ACROVASCULAR disease manifesting as coronary heart disease, cerebrovascular disease or peripheral vascular disease is the most important cause of morbidity and mortality in persons with diabetes mellitus.1),2) Non-diabetic persons with an abnormal oral glucose tolerance test are considered to be at increased risk for the development of coronary artery disease (CAD).3) Persons with mild glucose intolerance are hyperinsulinemic, and this may be a risk factor for CAD.4) Elevated plasma insulin levels have also been shown to be associated with hypertriglyceridemia5) and reduced plasma high-density lipoprotein cholesterol concentrations;6) both of these changes in lipid metabolism are identified as risk factors for coronary artery disease.7) However, few reports have demonstrated a relationship between coronary artery stenosis visualized by coronary arteriography and other risk factors in patients with abnormal glucose tolerance. This study examined risk factors in 225 patients with anginal symptoms, whose coronary atherosclerosis was estimated by selective coronary angiography. The analyses focused on a comparison of non-diabetic patients with impaired glucose tolerant and diabetic patients, to determine whether abnormal glucose metabolism is a risk factor for coronary atherosclerosis.
PATIENTS AND METHODS
Two hundred twenty five patients (37-75yr) with a history of chest pain (n=19), angina pectoris (n=138) or old myocardial infarction (n=68) admitted to Fukui Cardiovascular Center were studied. These patients had no diabetic symptoms and no history of glycosuria. Patients with familial hypercholesterolemia were excluded. They had not received antihypertensive drugs. After an overnight fast, blood pressure was measured in the supine position with a sphygmomanometer and venous blood samples were drawn to measure glucose, insulin, triglyceride, cholesterol, apolipoprotein A-I, B and E, and hemoglobin A1 and A1c levels. A 75g oral glucose load was performed and plasma glucose and insulin levels were determined after 1 hour and 2 hours. Plasma glucose, triglyceride and cholesterol levels were measured enzymatically; the high-density lipoprotein (HDL) cholesterol level was measured by means of phosphotungstate magnesium precipitation;8) the immunoreactive insulin levels were determined by radio-immunoassay;9) apolipoprotein A-I, B, E were assayed by the single radial immunodiffusion method;10) and hemoglobin A1 and A1c were measured by column chromatography.11)
Selective coronary arteriography was performed by the Judkins technique. Medications were discontinued before arteriography. The coronary artery system was divided into 15 segments, according to the classification of the American Heart Association Grading Committee. The extent and severity of coronary artery disease were assessed by assigning scores to each of the 15 segments. The coronary atherosclerosis index (CASI) was defined as the sum of these scores. Absence of significant stenosis was assigned grade 0; stenosis of less than 25%, grade 1; 25% to 49% stenosis, grade 2; 50% to 74% stenosis, grade 3; and 75% stenosis or more, grade 4 (Table I) . DM=subjects who showed a diabetic pattern during 75g OGTT; IGT=subjects who showed an impaired glucose tolerance pattern; Non-DM=subjects who showed a normal pattern. plasma triglycerides and the prevalence of hypertension were significantly higher in the persons with CAS (p<0.05). Plasma triglycerides were also higher in the diabetic patients and IGT patients with CAS than in the nondiabetic group with CAS; the prevalence of hypertension was also higher in the diabetic patients with CAS than in the non-diabetic group with CAS.
Correlation coefficients between CASI and risk factors in the 3 groups are listed in Table III . A significant correlation between CASI and plasma triglyceride was found in the IGT and diabetic groups.
DISCUSSION
It is well known that diabetes mellitus is associated with an increased frequency of coronary heart disease (CHD).13)-15) Several prospective population studies have also shown that subjects with IGT have an increased risk of morbidity and mortality from CHD.16),17) Our study was performed on a selected group of symptomatic patients, and revealed that the number of patients who have at least 75% or more narrowing of one or more major coronary vessels was increased in the diabetic and IGT patients, and that the coronary atherosclerosis indices were significantly elevated in the diabetic and IGT groups.
In prospective studies, a high serum cholesterol level has been shown to increase the risk of CHD in diabetic subjects to the same extent as in nondiabetic subjects.18) Our results showed that subjects with CAS in the IGT group had a significantly higher plasma total cholesterol level, but there was no correlation between plasma cholesterol and CASI in the same group. Uusitupa et al19) reported that serum total cholesterol was not related to the presence of CHD in a series of newly diagnosed Type 2 diabetic subjects.
In a study carried out on the Framingham cohort,17) low HDL-cholesterol was related to the incidence of CHD in diabetic subjects, and in some cross-sectional studies, low HDL-cholesterol was associated with vascular disease and with a previous myocardial infarction in middle-aged diabetic subjects.20),21) In our results, the subjects with diabetes had lower HDL-cholesterol levels than non-diabetic subjects, but there was no difference between the persons with CAS and those without CAS.
It is reported that hypertriglyceridemia is a significant risk factor for CHD in diabetic patients.22) Although both the plasma triglyceride levels and the body mass indices were significantly elevated in the diabetic and IGT subjects, there was no difference in body mass index between patients with CAS and those without CAS. The IGT and diabetic patients with CAS also had higher plasma triglyceride concentrations than the non-diabetic group with CAS. There was a positive correlation between plasma triglycerides and CASI in the diabetic and IGT groups but there was no correlation between body mass indices and CASI in either group. Fontbonne et al23) reported that hypertriglyceridemia is an important predictor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes by the results from the 11-year follow-up of the Paris Prospective Study. Our data supports the importance of plasma triglycerides as a risk factor for coronary atherosclerosis in these patient populations.
Hypertension is one of the major risk factors for coronary artery disease. In the Framingham study, the higher the blood pressure, the greater the incidence of coronary heart disease; blood pressure and serum cholesterol were correlated significantly.24) In our results the prevalence of hypertension was significantly higher in the subjects with diabetes than in the non-diabetic subjects, and also it was higher in the diabetic persons with CAS than in those without CAS. Thus, high plasma triglycerides and hypertension appear to be significant risk factors for coronary artery disease in patients with abnormal glucose tolerance.
